HeartSciences (HSCS) Cash & Equivalents (2022 - 2026)
HeartSciences' (HSCS) quarterly Cash & Equivalents came in at $1.7 million in Q2 2026, up 54.55% YoY from $1.1 million in Q2 2025, and up 54.81% on a QoQ basis from $1.1 million in Q4 2025.
HeartSciences (HSCS) Cash & Equivalents (2022 - 2026) Analysis & Trends
HeartSciences (HSCS) has 5 years of Cash & Equivalents data on file, last reported at $1.7 million in Q2 2026.
- Quarterly Cash & Equivalents rose 54.55% year-over-year to $1.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $1.7 million (up 54.55% YoY) and the FY2026 annual result came in at $1.7 million, up 54.55% from the prior year.
- Cash & Equivalents grew to $1.7 million in Q2 2026, from $1.1 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $7.1 million in Q1 2024 to a low of $100144.0 in Q4 2023.
- A 5-year average of $2.7 million and a median of $2.0 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 96.74% — and 2024, when it surged 3946.29%.
- Tracing HSCS's Cash & Equivalents over 5 years: stood at $3.1 million in 2022, then tumbled by 96.74% to $100144.0 in 2023, then surged by 3946.29% to $4.1 million in 2024, then plunged by 72.9% to $1.1 million in 2025, then jumped by 54.81% to $1.7 million in 2026.
- The last three Cash & Equivalents figures came in at $1.7 million (Q2 2026), $1.1 million (Q4 2025), and $2.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | HeartSciences | 6.54 Mn | 4.84 Mn | - | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Oct 31, 2025 | 1.95 Mn |
| Jul 31, 2025 | 2.79 Mn |
| Apr 30, 2025 | 1.10 Mn |
| Jan 31, 2025 | 2.60 Mn |
| Oct 31, 2024 | 4.05 Mn |
| Jul 31, 2024 | 4.34 Mn |
| Apr 30, 2024 | 5.81 Mn |
| Jan 31, 2024 | 7.08 Mn |
| Oct 31, 2023 | 100,144.00 |
| Jul 31, 2023 | 575,654.00 |
| Apr 30, 2023 | 1.70 Mn |
| Jan 31, 2023 | 1.93 Mn |
| Oct 31, 2022 | 3.08 Mn |
| Jul 31, 2022 | 4.27 Mn |
| Apr 30, 2022 | 918,260.00 |